Momordica charantia (Bitter Melon) reduces obesity-associated macrophage and mast cell infiltration as well as inflammatory cytokine expression in adipose tissues

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Bao, Bin ^a   Chen, Yan Guang ^a   Zhang, Lei ^a   Xu, Yan Lin Na ^a   Wang, Xin ^a   Liu, Jian ^a   Qu, Wei ^a  

^a HEFEI UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BROWN ADIPOSE TISSUE; C57BL 6 MOUSE; CONTROLLED STUDY; EPIDIDYMIS FAT; INFLAMMATORY INFILTRATE; INSULIN RESISTANCE; LIPID DIET; LIPID STORAGE; MACROPHAGE; MALE; MAST CELL; MOMORDICA CHARANTIA; MOUSE; NONHUMAN; OBESITY;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; CYTOKINES; DIET; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; MACROPHAGES; MALE; MAST CELLS; MICE; MOMORDICA CHARANTIA; OBESITY; PHENOTYPE;

EID: 84892934880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084075     Document Type: Article

References (45)

1. Grundy SM (2002) Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 105: 2696-2698. doi:10.1161/01.CIR. 0000020650.86137.84. PubMed: 12057978.
2. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH et al. (2010) Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 362: 485-493. doi:10.1056/NEJMoa0904130. PubMed: 20147714.
3. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M (2011) Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378: 815-825. doi:10.1016/S0140-6736(11)60814-3. PubMed: 21872750.
4. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808. doi:10.1172/JCI19246. PubMed: 14679176.
5. Altintas MM, Azad A, Nayer B, Contreras G, Zaias J et al. (2011) Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res 52: 480-488. doi: 10.1194/jlr.M011338. PubMed: 21148461.
6. Liu J, Divoux A, Sun J, Zhang J, Clément K et al. (2009) Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 15: 940-945. doi: 10.1038/nm.1994. PubMed: 19633655.
7. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE et al. (2007) T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115: 1029-1038. doi:10.1161/CIRCULATIONAHA.106.638379. PubMed: 17296858.
8. Chatzigeorgiou A, Karalis KP, Bornstein SR, Chavakis T (2012) Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 55: 2583-2592. doi:10.1007/s00125-012-2607-0. PubMed: 22733483.
9. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117: 175-184. doi:10.1172/JCI29881. PubMed: 17200717.
10. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11: 85-97. doi: 10.1038/nri2921. PubMed: 21252989.
11. Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18: 363-374. doi:10.1038/nm.2627. PubMed: 22395709.
12. Leung L, Birtwhistle R, Kotecha J, Hannah S, Cuthbertson S (2009) Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review. Br J Nutr 102: 1703-1708. doi:10.1017/S0007114509992054. PubMed: 19825210.
13. Fang EF, Ng TB (2011) Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties. Curr Mol Med 11: 417-436. doi: 10.2174/156652411795976583. PubMed: 21568930.
14. Tan MJ, Ye JM, Turner N, Hohnen-Behrens C, Ke CQ et al. (2008) Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol 15: 263-273. doi:10.1016/j. chembiol.2008.01.013. PubMed: 18355726.
15. Iseli TJ, Turner N, Zeng X-Y, Cooney GJ, Kraegen EW et al. (2013) Activation of AMPK by Bitter Melon Triterpenoids Involves CaMKKb. PLOS ONE 8(4): e62309. doi:10.1371/journal.pone.0062309. PubMed: 23638033.
16. Shih CC, Lin CH, Lin WL (2008) Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet. Diabetes Res Clin Pract 81: 134-143. doi:10.1016/j.diabres.2008.04.023. PubMed: 18550200.
17. Chao CY, Yin MC, Huang CJ (2011) Wild bitter gourd extract upregulates mRNA expression of PPARalpha, PPARgamma and their target genes in C57BL/6J mice. J Ethnopharmacol 135: 156-161. doi: 10.1016/j.jep.2011.03.001. PubMed: 21392566.
18. Nerurkar PV, Lee YK, Motosue M, Adeli K, Nerurkar VR (2008) Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions. Br J Nutr 100: 751-759. PubMed: 18321395.
19. Klomann SD, Mueller AS, Pallauf J, Krawinkel MB (2010) Antidiabetic effects of bitter gourd extracts in insulin-resistant db/db mice. Br J Nutr 104: 1613-1620. doi:10.1017/S0007114510002680. PubMed: 20615270.
20. Wang ZQ, Zhang XH, Yu Y, Poulev A, Ribnicky D et al. (2011) Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice. J Nutr Biochem 22: 1064-1073. doi:10.1016/j.jnutbio.2010.09.004. PubMed: 21277185.
21. Sridhar MG, Vinayagamoorthi R, Arul Suyambunathan V, Bobby Z, Selvaraj N (2008) Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats. Br J Nutr 99: 806-812. PubMed: 17942003.
22. Huang HL, Hong YW, Wong YH, Chen YN, Chyuan JH et al. (2008) Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats. Br J Nutr 99: 230-239. PubMed: 17651527.
23. Chan LL, Chen Q, Go AG, Lam EK, Li ET (2005) Reduced adiposity in bitter melon (Momordica charantia)-fed rats is associated with increased lipid oxidative enzyme activities and uncoupling protein expression. J Nutr 135: 2517-2523. PubMed: 16251604.
24. Nerurkar PV, Johns LM, Buesa LM, Kipyakwai G, Volper E et al. (2011) Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation. J Neuroinflammation 8: 64. doi:10.1186/1742-2094- 8-64. PubMed: 21639917.
25. Yu W, Liu J, Shi MA, Wang J, Xiang M et al. (2010) Cystatin C deficiency promotes epidermal dysplasia in K14-HPV16 transgenic mice. PLOS ONE 5: e13973. doi:10.1371/journal.pone.0013973. PubMed: 21085595.
26. Dalmas E, Clément K, Guerre-Millo M (2011) Defining macrophage phenotype and function in adipose tissue. Trends Immunol 32: 307-314. doi:10.1016/j.it.2011.04.008. PubMed: 21616718.
27. Rosen ED, Spiegelman BM (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444: 847-853. doi:10.1038/nature05483. PubMed: 17167472.
28. Hageman RS, Wagener A, Hantschel C, Svenson KL, Churchill GA et al. (2010) High-fat diet leads to tissue-specific changes reflecting risk factors for diseases in DBA/2J mice. Physiol Genomics 42: 55-66. doi: 10.1152/physiolgenomics.00072.2009. PubMed: 20215417.
29. Olefsky JM, Glass CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72: 219-246. doi:10.1146/annurev-physiol-021909- 135846. PubMed: 20148674.
30. Wang J, Shi GP (2011) Mast cell stabilization: novel medication for obesity and diabetes. Diabetes Metab Res Rev 27: 919-924. PubMed: 22069285.
31. Sun J, Sukhova GK, Wolters PJ, Yang M, Kitamoto S et al. (2007) Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 13: 719-724. doi:10.1038/nm1601. PubMed: 17546038.
32. Chen PH, Chen GC, Yang MF, Hsieh CH, Chuang SH et al. (2012) Bitter melon seed oil-attenuated body fat accumulation in diet-induced obese mice is associated with cAMP-dependent protein kinase activation and cell death in white adipose tissue. J Nutr 142: 1197-1204. doi:10.3945/jn.112.159939. PubMed: 22623391.
33. Chen Q, Li ET (2005) Reduced adiposity in bitter melon (Momordica charantia) fed rats is associated with lower tissue triglyceride and higher plasma catecholamines. Br J Nutr 93: 747-754. doi:10.1079/BJN20051388. PubMed: 15975176.
34. Chen Q, Chan LL, Li ET (2003) Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J Nutr 133: 1088-1093. PubMed: 12672924.
35. Gadang V, Gilbert W, Hettiararchchy N, Horax R, Katwa L et al. (2011) Dietary Bitter Melon Seed Increases Peroxisome Proliferator-Activated Receptor-c Gene Expression in Adipose Tissue, Down-Regulates the Nuclear Factor-kB Expression, and Alleviates the Symptoms Associated with Metabolic Syndrome. J Med Food 14: 86-93. doi: 10.1089/jmf.2010.0010. PubMed: 21128828.
36. Anila L, Vijayalakshmi NR (2000) Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia. Phytother Res 14: 592-595. doi:10.1002/1099-1573(200012)14:8. PubMed: 11113993.
37. Grover JK, Yadav SP (2004) Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol 93: 123-132. doi:10.1016/j.jep.2004.03.035. PubMed: 15182917.
38. Singh J, Cumming E, Manoharan G, Kalasz H, Adeghate E (2011) Medicinal chemistry of the anti-diabetic effects of Momordica charantia: active constituents and modes of actions. Open Med Chem. J. 5(Suppl 2): 70-77.
39. Harinantenaina L, Tanaka M, Takaoka S, Oda M, Mogami O et al. (2006) Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem Pharm Bull (Tokyo) 54: 1017-1021. doi:10.1248/cpb.54.1017. PubMed: 16819222.
40. Keller AC, Ma J, Kavalier A, He K, Brillantes AM et al. (2011) Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro. Phytomedicine 19: 32-37. doi:10.1016/j.phymed.2011.06.019. PubMed: 22133295.
41. Cheng HL, Kuo CY, Liao YW, Lin CC (2012) EMCD, a hypoglycemic triterpene isolated from Momordica charantia wild variant, attenuates TNF-alpha-induced inflammation in FL83B cells in an AMP-activated protein kinase-independent manner. Eur J Pharmacol 689: 241-248. doi:10.1016/j.ejphar.2012.05.033. PubMed: 22683870.
42. Chang CI, Tseng HI, Liao YW, Yen CH, Chen TM et al. (2011) In vivo and in vitro studies to identify the hypoglycemic constituents of Momordica charantia wild variant WB24. Food Chemistry 125: 521-528. doi:10.1016/j.foodchem.2010.09. 043.
43. Overman A, Chuang CC, McIntosh M (2011) Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophage-conditioned media. Int J Obes (Lond) 35: 1165-1172. doi: 10.1038/ijo.2010.272. PubMed: 21224828.
44. Sismanopoulos N, Delivanis DA, Alysandratos KD, Angelidou A, Therianou A et al. (2012) Mast cells in allergic and inflammatory diseases. Curr Pharm Des 18: 2261-2277. doi: 10.2174/138161212800165997. PubMed: 22390690.
45. Nerurkar PV, Lee YK, Nerurkar VR (2010) Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes. BMC Complement Altern Med 10: 34. doi: 10.1186/1472-6882-10-34. PubMed: 20587058.